{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T17:03:38Z","timestamp":1726506218646},"reference-count":34,"publisher":"Consortium Erudit","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["smq"],"abstract":"<jats:p>Cet article porte sur une recension des \u00e9crits sur l\u2019\u00e9valuation \u00e9conomique des traitements \u00e9prouv\u00e9s cognitivo-comportementaux et pharmacologiques des troubles anxieux. La recherche des articles pertinents s\u2019\u00e9chelonne de 1980 \u00e0 2008, \u00e0 partir des bases de donn\u00e9es \u00e9lectroniques du milieu m\u00e9dical et psychologique. Sept \u00e9tudes sont recens\u00e9es et portent sur le trouble panique, le trouble d\u2019anxi\u00e9t\u00e9 g\u00e9n\u00e9ralis\u00e9e, la phobie sp\u00e9cifique et la phobie sociale. Les traitements pharmacologiques et la psychoth\u00e9rapie cognitive-comportementale pr\u00e9sentent un rapport co\u00fbts-efficacit\u00e9 avantageux, particuli\u00e8rement lorsque compar\u00e9s aux soins usuels. Les auteurs concluent que malgr\u00e9 le besoin de renforcer l\u2019\u00e9tat des connaissances sur le rapport co\u00fbts-efficacit\u00e9 des interventions, il semble avantageux pour la soci\u00e9t\u00e9 d\u2019accro\u00eetre l\u2019acc\u00e8s aux traitements \u00e9prouv\u00e9s des troubles anxieux.<\/jats:p>","DOI":"10.7202\/044801ar","type":"journal-article","created":{"date-parts":[[2012,7,17]],"date-time":"2012-07-17T18:03:37Z","timestamp":1342548217000},"page":"129-152","source":"Crossref","is-referenced-by-count":2,"title":["Les \u00e9tudes de co\u00fbts-efficacit\u00e9 des traitements pharmacologiques et psychologiques des troubles anxieux\u00a0: une recension des \u00e9crits"],"prefix":"10.7202","volume":"35","author":[{"given":"Joannie","family":"Poirier-Bisson","sequence":"first","affiliation":[{"name":"\u00c9tudiante au doctorat en psychologie, Ph.D. (c), Universit\u00e9 du Qu\u00e9bec \u00e0 Montr\u00e9al"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Roberge","sequence":"additional","affiliation":[{"name":"Ph.D., Universit\u00e9 de Montr\u00e9al, Institut national de sant\u00e9 publique du Qu\u00e9bec, CRCHUM"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Marchand","sequence":"additional","affiliation":[{"name":"Ph.D., Universit\u00e9 du Qu\u00e9bec \u00e0 Montr\u00e9al et Centre de recherche Fernand-S\u00e9guin de l\u2019H\u00f4pital Louis-H. Lafontaine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Gr\u00e9goire","sequence":"additional","affiliation":[{"name":"\u00c9tudiante au doctorat en psychologie, Ph.D. (c), Universit\u00e9 du Qu\u00e9bec \u00e0 Montr\u00e9al"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4194","published-online":{"date-parts":[[2010,10,26]]},"reference":[{"key":"rb1","unstructured":"Agence canadienne des m\u00e9dicaments et des technologies de la sant\u00e9, 2006, Lignes directrices de l\u2019\u00e9valuation \u00e9conomique des technologies de la sant\u00e9 au Canada, 3e \u00e9dition, Ottawa."},{"key":"rb2","unstructured":"Association des psychiatres du Canada, 2006, Guide de pratique clinique\u00a0: Traitement des troubles anxieux, La Revue canadienne de psychiatrie, 51, suppl\u00e9ment 2, 1s-97s."},{"key":"rb3","doi-asserted-by":"publisher","unstructured":"Baldwin, D. S., Anderson, I.\u00a0M, Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T, Den Boer, J. A., Fineberg, N.A., Knapp, M., Scott, J., Wittchen, H. U, 2005, Evidence-based guidelines for the pharmacological treatment of anxiety disorders\u00a0: recommendations from the British Association for psychopharmacology, Journal of Psychopharmacology, 19, 6, 567-596.","DOI":"10.1177\/0269881105059253"},{"key":"rb4","doi-asserted-by":"publisher","unstructured":"Barlow, D. H., Gorman, J. M., Shear, M. K., Woods, S. W., 2000, Cognitive-behavioral therapy, imipramine, or their combination for panic disorder. A randomized controlled trial, JAMA, 283, 19, 2529-2536.","DOI":"10.1001\/jama.283.19.2529"},{"key":"rb5","unstructured":"Bower, P., Richards, D., Lovell, K., 2001, The clinical and cost-effectiveness of self-help treatments for anxiety and depressive disorders in primary care\u00a0: a systematic review, British Journal of General Practice, 51, 471, 838-845."},{"key":"rb6","doi-asserted-by":"publisher","unstructured":"Briggs, A. H., 2001, A Bayesian approach to stochastic cost-effectiveness analysis, International Journal of Technology Assessment in Health Care, 17, 1, 69-82.","DOI":"10.1017\/S0266462301104071"},{"key":"rb7","doi-asserted-by":"publisher","unstructured":"Cavanagh, K., Shapiro, D. A., 2004, Computer treatment for common mental health problems, Journal of Clinical Psychology, 60, 3, 239-251.","DOI":"10.1002\/jclp.10261"},{"key":"rb8","unstructured":"Cochrane Effective Practice and Organisation of Care Review Group (EPOC), 2002, http:\/\/www.epoc.cochrane.org\/en\/handsearchers.html, consult\u00e9 le 24\u00a0septembre 2008."},{"key":"rb9","unstructured":"Drummond, M. F., O\u2019Brien, B., Stoddart, G. L., Torrance, G. W., 1997, Methods for the Economic Evaluation of Health Care Programmes, 2nd edition, Oxford University Press, New York."},{"key":"rb10","unstructured":"Duhoux, A., Fournier, L., Nguyen, C., Roberge, P., Beveridge, R., sous presse, Guideline concordance of treatment for depressive disorders in Canada, Social Psychiatry and Psychiatric Epidemiology."},{"key":"rb11","doi-asserted-by":"publisher","unstructured":"Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R., Ballenger, J. C., Fyer, A. J., 1999, The economic burden of anxiety disorders in the 1990s, The Journal of Clinical Psychiatry, 60, 7, 427-435.","DOI":"10.4088\/JCP.v60n0702"},{"key":"rb12","doi-asserted-by":"publisher","unstructured":"Hoch, J. S., Smith, M. W., 2006, A guide to economic evaluation\u00a0: methods for cost-effectiveness analysis of person-level data, Journal of Traumatic Stress, 19, 6, 787-797.","DOI":"10.1002\/jts.20190"},{"key":"rb13","doi-asserted-by":"publisher","unstructured":"Issakidis, C., Andrews, G., 2002, Service utilisation for anxiety in an Australian community sample, Social Psychiatry And Psychiatric Epidemiology, 37, 4, 153-163.","DOI":"10.1007\/s001270200009"},{"key":"rb14","doi-asserted-by":"publisher","unstructured":"Issakidis, C., Sanderson, K., Corry, J., Andrews, G., Lapsley, H., 2004, Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders, Psychological Medicine, 34, 1, 19-35.","DOI":"10.1017\/S003329170300881X"},{"key":"rb15","doi-asserted-by":"crossref","unstructured":"Kaltenthaler, E., Shackley, P., Stevens, K., Beverley, C., Parry, G., Chilcott, J., 2002, A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety, Health Technology Assessment, 6, 22, 1-89.","DOI":"10.3310\/hta6220"},{"key":"rb16","doi-asserted-by":"publisher","unstructured":"Katon, W., Russo, J., Sherbourne, C., Stein, M.\u00a0B., Craske, M., Fan, M.-Y., Roy-Byrne, P., 2006, Incremental cost-effectiveness of a collaborative care intervention for panic disorder, Psychological Medicine, 36, 3, 353-363.","DOI":"10.1017\/S0033291705006896"},{"key":"rb17","doi-asserted-by":"crossref","unstructured":"Leon, A. C., Portera, L., Weissman, M. M., 1995, The social costs of anxiety disorders, British Journal of Psychiatry, Supplement, 27, 19-22.","DOI":"10.1192\/S0007125000293355"},{"key":"rb18","doi-asserted-by":"publisher","unstructured":"Marchand, A., Germain, V., Reinharz, D., Mainguy, N., Landry, P., 2004, Analyse des co\u00fbts et de l\u2019efficacit\u00e9 d\u2019une psychoth\u00e9rapie pour le Trouble panique avec agoraphobie versus un traitement combinant la pharmacoth\u00e9rapie et la psychoth\u00e9rapie, Sant\u00e9 mentale au Qu\u00e9bec, 29, 2, 201-220.","DOI":"10.7202\/010837ar"},{"key":"rb19","doi-asserted-by":"publisher","unstructured":"McCrone, P., Knapp, M., Proudfoot, J., Ryden, C., Cavanagh, K., Shapiro, D.A., Ilson, S., Gray, J. A., Goldberg, D., Mann, A., Marks, I., Everitt, B., Tylee, A., 2004, Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care\u00a0: randomised controlled trial, British Journal of Psychiatry, 185, 55-62.","DOI":"10.1192\/bjp.185.1.55"},{"key":"rb20","doi-asserted-by":"publisher","unstructured":"McHugh, R.K., Otto, M.W., Barlow, D.H., Gorman, J.M., Shear, M.K., Woods, S.W., 2007, Cost-efficacy of individual and combined treatments for panic disorder, Journal Of Clinical Psychiatry, 68, 7, 1038-1044.","DOI":"10.4088\/JCP.v68n0710"},{"key":"rb21","unstructured":"Minist\u00e8re de la sant\u00e9 et des services sociaux (MSSS), 2005, Plan d\u2019action en sant\u00e9 mentale 2005-2010\u00a0: La force des liens, Qu\u00e9bec."},{"key":"rb22","doi-asserted-by":"publisher","unstructured":"Murray, C. J. L., Evans, D. B., Acharya, A., Baltussen, R. M., 2000, Development of WHO guidelines on generalized cost-effectiveness analysis, Health Economics, 9, 3, 235-251.","DOI":"10.1002\/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O"},{"key":"rb23","unstructured":"Netten, A., Curtis, l., 2000, Units Costs of Health and Social Care, Canterbury, PSSRU."},{"key":"rb24","unstructured":"Organisation mondiale de la sant\u00e9, Rapport sur la sant\u00e9 dans le monde 2001, La sant\u00e9 mentale, nouvelle conception, nouveaux espoirs, Organisation mondiale de la sant\u00e9."},{"key":"rb25","doi-asserted-by":"publisher","unstructured":"Otto, M. W., Pollack, M. H., Maki, K. M., 2000, Empirically-supported treatments for panic disorder\u00a0: costs, benefits, and stepped care, Journal of Consulting and Clinical Psychology, 68, 4, 556-563.","DOI":"10.1037\/0022-006X.68.4.556"},{"key":"rb26","doi-asserted-by":"publisher","unstructured":"Roberge, P.\u00a0Marchand, A., Reinharz, D., Savard, P., 2008, Cognitive-behavioral treatment for panic disorder with agoraphobia., A randomized controlled trial and cost-effectiveness analysis, Behavior Modification, 32, 3, 333-351.","DOI":"10.1177\/0145445507309025"},{"key":"rb27","doi-asserted-by":"publisher","unstructured":"Roy, S., Madhavan, S. S., 2008, Making a case for employing a societal perspective in the evaluation of Medicaid prescription drug interventions, Pharmacoeconomics, 26, 4, 281-296.","DOI":"10.2165\/00019053-200826040-00002"},{"key":"rb28","unstructured":"Roy-Byrne, P. P., Wagner, A. W., Schraufnagel, T. J., 2005, Understanding and treating panic disorder in the primary care setting, Journal Of Clinical Psychiatry, 66, Suppl 4, 16-22."},{"key":"rb29","doi-asserted-by":"crossref","unstructured":"Somers, J. M., Goldner, E. M., Waraich, P., Hsu, L., 2006, Prevalence and incidence studies of anxiety disorders\u00a0: a systematic review of the literature, Canadian Journal of Psychiatry, 51, 2, 100-113.","DOI":"10.1177\/070674370605100206"},{"key":"rb30","doi-asserted-by":"crossref","unstructured":"Stant, A. D., Ten Vergert, E. M., den Boer, P. C. A. M., Wiersma, D., 2008, Cost-effectiveness of cognitive self-therapy in patients with depression and anxiety disorders, Acta Psychiatrica Scandinavica, 117, 1, 57-66.","DOI":"10.1111\/j.1600-0447.2007.01122.x"},{"key":"rb31","doi-asserted-by":"publisher","unstructured":"Stein, M. B., Sherbourne, C. D., Craske, M. G., Means-Christensen, A., Bystritsky, A., Katon, W., Sullivan, G., Roy-Byrne, P. P., 2004, Quality of care for primary care patients with anxiety disorders, American Journal of Psychiatry, 161, 12, 2230-2237.","DOI":"10.1176\/appi.ajp.161.12.2230"},{"key":"rb32","doi-asserted-by":"publisher","unstructured":"van Roijen, L.H., van Straten, A., Al, M., Rutten, F., Donker, M., 2006, Cost-utility of brief psychological treatment for depression and anxiety, British Journal of Psychiatry, 188, 323-329.","DOI":"10.1192\/bjp.188.4.323"},{"key":"rb33","doi-asserted-by":"publisher","unstructured":"Wang, P. S., Berglund, P., Kessler, R. C., 2000, Recent care of common mental disorders in the United States\u00a0: prevalence and conformance with evidence-based recommendations, Journal of General Internal Medicine, 15, 5, 284-292.","DOI":"10.1046\/j.1525-1497.2000.9908044.x"},{"key":"rb34","doi-asserted-by":"publisher","unstructured":"Young, A. S., Klap, R., Sherbourne, C. D., Wells, K. B., 2001, The quality of care for depressive and anxiety disorders in the United States, Archives of General Psychiatry, 58, 1, 55-61.","DOI":"10.1001\/archpsyc.58.1.55"}],"container-title":["Sant\u00e9 mentale au Qu\u00e9bec"],"original-title":[],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T01:26:27Z","timestamp":1714181187000},"score":1,"resource":{"primary":{"URL":"http:\/\/id.erudit.org\/iderudit\/044801ar"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,26]]},"references-count":34,"issue-title":["Mosa\u00efques"],"journal-issue":{"issue":"1"},"alternative-id":["044801ar"],"URL":"https:\/\/doi.org\/10.7202\/044801ar","relation":{},"ISSN":["1708-3923","0383-6320"],"issn-type":[{"type":"electronic","value":"1708-3923"},{"type":"print","value":"0383-6320"}],"subject":[],"published":{"date-parts":[[2010,10,26]]}}}